Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Biochem Pharmacol ; 62(5): 569-80, 2001 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-11585054

RESUMEN

Leishmania, a parasitic protozoan, infects human macrophages, often causing severe morbidity and mortality. The pathogenic form of this parasite, the amastigote, lives inside the acidic phagolysosomes of infected macrophages. In our attempt to develop anti-miniexon phosphorothioate oligodeoxyribonucleotides (S-oligos) as an alternative chemotherapy against Leishmania, we found that intracellular as well as 'axenic' amastigotes were more susceptible to these S-oligos than were the cultured promastigotes. Lower pH (4.5) and elevated temperature (35 degrees) of the medium were among the direct enhancing factors for killing. Addition of the cationic polypeptide poly-l-lysine (PLL) to the growth medium further enhanced the killing effect of the S-oligo at pH 4.5. The enhancement of specific ablation of mRNA expression was directly correlated to the increased leishmanicidal activity of the S-oligo. This was shown by the increased inhibition of luciferase activity expressed in transgenic Leishmania amazonensis promastigotes by anti-miniexon S-oligo or anti-luciferase S-oligo at acidic pHs and in the presence of PLL. The leishmanicidal effects of S-oligos at acidic pH and in the presence of PLL were related to increased uptake of the S-oligos under these conditions. The rate of S-oligo uptake was enhanced up to 15-fold at pH 4.5. The addition of PLL to the assay medium at acidic pH further enhanced the uptake of S-oligo up to 80-fold. RNase H is known to accentuate the antisense action of S-oligos. We found that at an elevated temperature RNase H activity in Leishmania cell extracts increased about 5-fold. Thus, enhanced uptake of S-oligos at the acidic pH of macrophage phagolysosomes and activation of RNase H may explain the efficient killing of the parasite in macrophages, both in tissue culture and in the animal model, by antisense miniexon oligonucleotide/PLL, when targeted directly to the parasite-containing phagolysosomes.


Asunto(s)
Leishmania/efectos de los fármacos , Oligodesoxirribonucleótidos Antisentido/farmacología , Polilisina/farmacología , Ribonucleasa H/metabolismo , Tionucleótidos/farmacología , Animales , Modelos Animales de Enfermedad , Portadores de Fármacos , Sistemas de Liberación de Medicamentos , Interacciones Farmacológicas , Activación Enzimática , Vida Libre de Gérmenes/efectos de los fármacos , Concentración de Iones de Hidrógeno , Leishmania/metabolismo , Leishmaniasis/tratamiento farmacológico , Liposomas , Luciferasas/biosíntesis , Luciferasas/efectos de los fármacos , Macrófagos/efectos de los fármacos , Macrófagos/parasitología , Ratones , Ratones Endogámicos BALB C , Oligodesoxirribonucleótidos Antisentido/farmacocinética , Oligodesoxirribonucleótidos Antisentido/uso terapéutico , Pruebas de Sensibilidad Parasitaria , Fagosomas/efectos de los fármacos , Fagosomas/parasitología , Temperatura , Tionucleótidos/farmacocinética , Tionucleótidos/uso terapéutico , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA